Handheld ultrasound patent dispute
This article was originally published in The Gray Sheet
Executive Summary
SonoSite countersues General Electric July 5 in response to a patent infringement claim regarding ultrasound technology filed by GE May 15 in a U.S. District Court in Wisconsin. The patents in question involve miniaturizing ultrasound equipment to make it easily portable. SonoSite, spun off from ATL Ultrasound in 1999, offers five different "mini-laptop-sized" ultrasound systems including MicroMaxx and Titan. GE markets several compact ultrasound products of its own, including Logiq i and Vivid i, as part of its diversified imaging portfolio...
You may also be interested in...
GE/SonoSite suits settled
GE will pay the maker of the MicroMaxx point-of-care ultrasound device $21 million, as well as ongoing royalties until 2016, on U.S. hand-held ultrasound systems that weigh less than 10 pounds, under a settlement announced Oct. 19. In exchange, GE gets rights to SonoSite's U.S. Patent No. 5,722, 412. The agreement settles all pending litigation between the companies, including a GE lawsuit to invalidate the patent (1"The Gray Sheet" July 9, 2007)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.